{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:49:06Z","timestamp":1788306546569,"version":"build-2803163510"},"reference-count":17,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Educ Pract Ed"],"accepted":{"date-parts":[[2019,9,30]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Bronchiolitis is a common viral illness which can lead to severe respiratory compromise and can coexist with or mask cardiac failure. Brain natriuretic peptide (BNP) and the inactive portion of its pro-hormone: N-terminal pro-BNP (NT-proBNP) are excreted in response to cardiomyocyte stretching and are established biomarkers in cardiac failure. Here, we discuss the technicalities of NT-proBNP testing and review available evidence regarding NT-proBNP testing in bronchiolitis. We identified and appraised seven studies assessing the role of BNP or NT-proBNP as biomarkers of bronchiolitis severity, in children with and without underlying congenital cardiac disease. One study of 76 children with dyspnoea showed that the median NT-proBNP level in children with cardiac failure was 7321\u2009pg\/mL vs 241\u2009pg\/mL in children with a respiratory cause of dyspnoea vs 87.21\u2009pg\/mL in healthy controls (p&lt;0.05). A cut-off of 726\u2009pg\/mL could aid differentiation between cardiac and respiratory causes of respiratory distress. Other evidence showed a positive correlation between BNP levels and bronchiolitis severity, and that raised BNP can predict acute heart failure in children with congenital cardiac disease presenting with bronchiolitis. However, most studies consisted of small cohorts with conflicting evidence between them. Furthermore, several studies assessed BNP rather than NT-proBNP directly. BNP has a shorter half-life, which may affect analysis. In conclusion, NT-proBNP is a rapid and inexpensive test with the potential to be a useful biomarker in severe bronchiolitis and cases complicated by acute cardiac failure. However, studies with larger cohorts are required to better establish this role.<\/jats:p>","DOI":"10.1136\/archdischild-2019-316896","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T18:00:03Z","timestamp":1571162403000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["How to use N-terminal pro-brain natriuretic peptide (NT-proBNP) in assessing disease severity in bronchiolitis"],"prefix":"10.1136","volume":"105","author":[{"given":"Keir Dan","family":"Edwards","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Poole Hospital NHS Foundation Trust, Poole, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Peter","family":"Tighe","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Poole Hospital NHS Foundation Trust, Poole, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"2025090501332730000_105.5.282.1","unstructured":"QualtyWatch . Focus on: emergency hospital care for children and young people, 2017. Available: http:\/\/www.qualitywatch.org.uk\/sites\/files\/qualitywatch\/field\/field_document\/QualityWatch%20CYP%20report.pdf [Accessed 20 Nov 2018]."},{"key":"2025090501332730000_105.5.282.2","unstructured":"Nice Guideline NG9 . Bronchiolitis in children: diagnosis and management, 2015. Available: www.nice.org.uk\/guidance\/ng9 [Accessed 11 Nov 2018]."},{"key":"2025090501332730000_105.5.282.3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4253","article-title":"Predicting Escalated care in infants with bronchiolitis","volume":"142","author":"Freire","year":"2018","journal-title":"Pediatrics"},{"key":"2025090501332730000_105.5.282.4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ijcard.2016.07.109","article-title":"Brain natriuretic peptide: much more than a biomarker","volume":"221","author":"Calzetta","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025090501332730000_105.5.282.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2005.04.009"},{"key":"2025090501332730000_105.5.282.6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2147\/COPD.S134953","article-title":"Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction","volume":"12","author":"Adrish","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025090501332730000_105.5.282.7","unstructured":"Sodhi R . \u201cN-terminal pro B-type natriuretic peptide\u201d Association for clinical Biochemistry and LaboratoryMedicine 2014."},{"key":"2025090501332730000_105.5.282.8","unstructured":"Nice Guideline NG106 . Chronic heart failure in adults: diagnosis and management, 2018. Available: https:\/\/www.nice.org.uk\/guidance\/ng106\/evidence\/full-guideline-pdf-6538850029 [Accessed 20 Nov 2018]."},{"key":"2025090501332730000_105.5.282.9","doi-asserted-by":"crossref","DOI":"10.24953\/turkjped.2017.05.009","article-title":"B-Type natriuretic peptide is a useful biomarker predicting disease severity in children with isolated bronchiolitis in the emergency department","volume":"59","author":"An\u0131l","year":"2017","journal-title":"Turk J Pediatr"},{"key":"2025090501332730000_105.5.282.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010440","article-title":"Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: a prospective cohort study","volume":"6","author":"Usuda","year":"2016","journal-title":"BMJ Open"},{"key":"2025090501332730000_105.5.282.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-010-0140-z"},{"key":"2025090501332730000_105.5.282.12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajem.2015.02.005","article-title":"Brain natriuretic peptide: the reason of respiratory distress is heart disease or lung disease?","volume":"33","author":"Sahingozlu","year":"2015","journal-title":"Am J Emerg Med"},{"key":"2025090501332730000_105.5.282.13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ajem.2014.09.005","article-title":"Diagnosing heart failure in children with congenital heart disease and respiratory syncytial virus bronchiolitis","volume":"32","author":"Samuel","year":"2014","journal-title":"Am J Emerg Med"},{"key":"2025090501332730000_105.5.282.14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1047951110000533","article-title":"The value of serum N-terminal pro-brain natriuretic peptide levels in the differential diagnosis and follow-up of congestive cardiac failure and respiratory distress due to pulmonary aetiologies in infants and children","volume":"20","author":"Sezgin Evim","year":"2010","journal-title":"Cardiol Young"},{"key":"2025090501332730000_105.5.282.15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00246-003-0578-0","article-title":"Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress","volume":"25","author":"Koulouri","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"2025090501332730000_105.5.282.16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/ped.12258","article-title":"N-Terminal pro-brain natriuretic peptide in the assessment of respiratory distress in term neonates","volume":"56","author":"Markovic-Sovtic","year":"2014","journal-title":"Pediatr Int"},{"key":"2025090501332730000_105.5.282.17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1429"}],"container-title":["Archives of disease in childhood - Education &amp; practice edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-316896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:34:13Z","timestamp":1757061253000},"score":1,"resource":{"primary":{"URL":"https:\/\/ep.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-316896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,9,21]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/archdischild-2019-316896"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-316896","relation":{},"ISSN":["1743-0585","1743-0593"],"issn-type":[{"value":"1743-0585","type":"print"},{"value":"1743-0593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}